double

Verofax facilitates Egyptian EU Export with CBAM Compliance and Lifecycle Assessment Solutions

  Egyptian Businessmen's Association (EBA) convenes export symposium on February 9 CAIRO, Feb 15, 2024 - (ACN Newswire) - The Egyptian Businessmen's Association (EBA) convened a symposium on February 9, chaired by Engineer Majd al-Din al-Manzalawi, Secretary-General and Chairman of the Association’s Industry and Scientific Research Committee, to address the challenges and opportunities presented by the Carbon Border Adjustment Mechanism (CBAM), a law governing manufacturing standards for Egyptian exporters. [caption id="attachment_2481553" align="alignnone" width="780"] The Egyptian Businessmen's Association (EBA) convened to discuss the importance of technology in keeping factories compliant with export

Clockout Breaks New Ground in Wage Access. Launches and Expands its Reach to 42 States

Historically, on-demand wage access required significant backend adjustments, coordination and often posed integration hurdles for employers. Clockout, a cutting-edge fintech platform, is pushing the boundaries of the traditional earned wage access model. In a bold move to address common industry challenges, the company has unveiled a streamlined, implementation-free model for employers, eliminating the need for cumbersome contracts and implementations and making offering their workforce immediate access to earned wages effortless. Clockout amplifies businesses' employee motivation, retention, and hiring leverage; while placing the power directly in the hands of the employees

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

ROI and the True Cost of Making a Movie

What is the true value of a movie? If you’re a fan, it’s the satisfaction of the movie experience, perhaps with your investment of time or money in mind. For an investor, it’s more about the money, specifically their part of a movie’s return on investment (ROI). Although the interests of fans and investors differ, they have something in common—many films don’t meet the mark for either of them. What Is Movie ROI for an Investor, Exactly? Basically, ROI for a film investor is the percentage of profit (or loss)